Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Eli Lilly and Co

Recent news which mentions Eli Lilly and Co

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Healthy Returns: Eli Lilly’s chief scientific officer breaks down the latest obesity pill data
Tags Health care industry Health & Science Novo Nordisk A/S
From CNBC.com News
Trump fires Fed's Cook, Musk sues Apple and OpenAI, Netflix's theatrical run and more in Morning Squawk
Tags Business Netflix Inc Technology
From CNBC.com News
Eli Lilly’s weight loss pill orforglipron clears its latest trial, paving way for approval
Tags Eli Lilly and Co Pharmaceuticals US: News
From CNBC.com News
A world on weight loss drugs: How GLP-1s are reshaping the economy
Tags Health & Science Economy Zealand Pharma A/S
From CNBC.com News
Eli Lilly's obesity pill remains a viable rival to Novo's oral Wegovy despite data that underwhelmed investors
Tags Eli Lilly and Co Pharmaceuticals US: News
From CNBC.com News
CNBC's UK Exchange newsletter: The price is REIT
Tags Business News Europe Politics Business
From CNBC.com News
FDA approves first-ever glucose monitoring system for weight loss from Signos
Tags US: News Pharmaceuticals Eli Lilly and Co
From CNBC.com News
Viking Therapeutics shares fall more than 30% on disappointing obesity pill trial data
Tags Viking Therapeutics Inc Biotech and Pharmaceuticals Biotechnology
From CNBC.com News
Novo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients
Tags Health care industry Companies Health & Science
From CNBC.com News
'Don't quit the market' when it's frothy, says Jim Cramer. Here's why
Tags U/S/ Markets Mad Money Investment Strategy
From CNBC.com News
Eli Lilly hikes price of diabetes drug Mounjaro in UK as Trump pressures pharma to align drug costs
Tags Biotech and Pharmaceuticals Business News Biotechnology
From CNBC.com News
Cramer's Lightning Round: Affirm is a buy
Tags Affirm Holdings Inc S&P 500 Market Outlook
From CNBC.com News
5 things to know before the Thursday open: Chip tariffs | Cook's White House visit | Wall Street's fashionista
Tags Dine Brands Global Business Novo Nordisk A/S
From CNBC.com News
Eli Lilly hikes 2025 outlook, tops quarterly estimates as Mounjaro, Zepbound sales soar
Tags Biotech and Pharmaceuticals Business News Earnings
From CNBC.com News
Eli Lilly's obesity pill led to more than 12% weight loss in closely watched late-stage trial, paving way for approval
Tags Pharmaceuticals US: News Eli Lilly and Co
From CNBC.com News
Healthy Returns: Medicare, Medicaid will reportedly pilot covering obesity drugs – a potential win for drugmakers
Tags Roche Holding AG Biotech and Pharmaceuticals Social issues
From CNBC.com News
5 things to know before the Monday open: Berkshire's tariff fears | Ethereum turns 10 | Restaurants embrace spicy
Tags Politics McDonald's Corp Business News
From CNBC.com News
Cramer's week ahead: Earnings from Palantir, Berkshire Hathaway, Disney and McDonald's
Tags Berkshire Hathaway Inc Novo Nordisk A/S Warner Bros Discovery Inc
From CNBC.com News
Trump's drug price ultimatum sets pharma firms scrambling
Tags Merck & Co Inc Novo Nordisk A/S Regeneron Pharmaceuticals Inc
From CNBC.com News
Eli Lilly’s Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity
Tags Health care industry Health & Science Companies
From CNBC.com News
Trump's pharmaceutical tariffs could affect some drugmakers more than others
Tags Biogen Inc Pharmaceuticals Zoetis Inc
From CNBC.com News
Weight loss drugs could be a gamechanger for women with a common hormonal disorder
Tags Health care industry Companies Health & Science
From CNBC.com News
Healthy Returns: Chinese obesity drug emerges as a potential rival to Eli Lilly’s Zepbound
Tags Health & Science Health care industry Regeneron Pharmaceuticals Inc
From CNBC.com News
Cramer's Lightning Round: Rocket Lab is a buy
Tags Power Solutions International Inc S&P 500 Conagra Brands Inc
From CNBC.com News
Trump's 200% tariff threat leaves pharma firms scrambling with scenario planning
Tags Novartis AG Europe Markets Roche Holding AG
From CNBC.com News
Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Biotechnology
From CNBC.com News
Trump threatens to put up to 200% tariff on pharmaceuticals 'very soon'
Tags Johnson & Johnson AbbVie Inc US: News
From CNBC.com News
Wednesday's big stock stories: What’s likely to move the market in the next trading session
Tags Exxon Mobil Corp Jack in the Box Inc Chevron Corp
From CNBC.com News
Port strike fallout: Blockbuster weight-loss drug supply from Wegovy to Ozempic, Mounjaro, Zepbound caught up in East Coast trade shutdown
Tags Labor Unions Breaking News: Economy Trade
From CNBC.com News
East and Gulf Coast ports strike, with ILA longshoremen walking off job, stranding billions in trade
Tags Labor issues Marine Ports and Services U/S/ Economy
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.